www.lexpert.ca 17
BIOLOGICS IN CANADA, 2018
• $7.7 BILLION: sales of
biologic medicines In
Canada in 2018, which
tripled over the previous
decade and accounted
for almost one-third of
all pharmaceutical sales
• 1.9%: proportion of
Canadian biologic
spending on 'biosimilars':
biologic medical products
highly similar to other
approved biological
medicines
cannabis sector is still strong, says Gravelle,
"but now we're seeing this psilocybin/
psychedelics/mushroom space expanding
and sandwiched with COVID, which we
never expected."
Revised patented drug pricing regime
e new Patented Medicine Prices Review
Board (PMPRB) regulations were published
in August 2019. ey originally were meant
to take effect on July 1, 2020, then Jan. 1,
2021 and now July 1, all due to the pandemic.
at date could move again, says Lainson.
e Patented Medicine Regulations
were substantially amended in 2019 and
added three new factors the PMPRB must
consider in determining whether the price
of a patented medicine sold in Canada is
SOURCE: Patented Medicine Prices Review Board
